Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
  • Users Online: 148848
  • Home
  • Print this page
  • Email this page

   Table of Contents      
Year : 2019  |  Volume : 67  |  Issue : 12  |  Page : 2058-2059

Ultra-widefield angiographic imaging of albumin-bound paclitaxel-induced cystoid macular edema

Department of Ophthalmology, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, South Korea

Date of Submission13-Apr-2019
Date of Acceptance08-Aug-2019
Date of Web Publication22-Nov-2019

Correspondence Address:
Dr. Jiwon Baek
Department of Ophthalmology, Bucheon St. Maryfs Hospital, College of Medicine, The Catholic University of Korea, Seoul
South Korea
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/ijo.IJO_734_19

Rights and Permissions

Keywords: Albumin-bound paclitaxel, angiography, cystoid macular edema, paclitaxel, ultra-widefield angiography

How to cite this article:
Lee J, Ra H, Baek J. Ultra-widefield angiographic imaging of albumin-bound paclitaxel-induced cystoid macular edema. Indian J Ophthalmol 2019;67:2058-9

How to cite this URL:
Lee J, Ra H, Baek J. Ultra-widefield angiographic imaging of albumin-bound paclitaxel-induced cystoid macular edema. Indian J Ophthalmol [serial online] 2019 [cited 2020 Aug 9];67:2058-9. Available from: http://www.ijo.in/text.asp?2019/67/12/2058/271394

A 43-year-old female presented with decreased bilateral visual acuity for 3 months. She was receiving albumin-bound paclitaxel (Abraxane®) chemotherapy due to pancreatic cancer for the previous 7 months. Cystoid macular edema (CME) was evident in both eyes on color fundus photograpy and optical coherence tomography imaging (Cirrus HD-OCT 4000; Carl Zeiss Meditec, Inc., USA) [Figure 1]a and [Figure 1]b. On UWF fluorescein angiography (FA) (P200DTx California; Optos, Inc., Marlborough, MA, USA), absent or minimal late phase leakage was observed at the fovea [Figure 2]a, and no abnormality on the peripheral retinal vessel was observed at the peripheral retina [Figure 2]b. UWF indocyanine green angiography (ICGA) revealed almost no leakage at the fovea [Figure 2]c and no abnormal findings, including increased permeability, large vessel dilation, and vortex ampullae at the peripheral retina [Figure 2]d. Paclitaxel was discontinued and the regimen was replaced by Oxaliplatin (Oxalitin®) and Capecitabine (Xelobig®). Two weeks after withdrawal of the paclitaxel, improvement of CME was observed [Figure 3]a, and no CME was evident at month 3 [Figure 3]b.
Figure 1: Ultra-widefield color fundus photography and optical coherence tomography at the patient's initial visit. (a) Color fundus photography revealed no abnormality in either eye. (b) Optical coherence tomography revealed cystoid macular edema in both eyes

Click here to view
Figure 2: Ultra-widefield fluorescein angiography and indocyanine green angiography at the patient's initial visit. (a) Late-phase ultra-widefield (UWF) fluorescein angiography (FA) of the fovea showed minimal leakage in the right eye and no leakage in the left eye. (b) Late-phase UWF FA of the peripheral retina revealed no abnormal findings in either eye. (c) Late-phase UWF ICGA showed no abnormal findings at the fovea in either eye. (d) Late-phase UWF ICGA revealed no abnormal findings, including choroidal vascular hyperpermeability, large vessel dilation, or vortex ampullae obstruction

Click here to view
Figure 3: Follow-up optical coherence tomography image of the patient after withdrawal of paclitaxel. (a) Optical coherence tomography (OCT) 2 weeks after cessation of the paclitaxel revealed disappearance of the cystoid macular edema. (b) OCT image at 3 months revealed no intraretinal fluid in either eye

Click here to view

The suggested hypotheses for CME after paclitaxel use include increased capillary fluid filtration, toxicity to Müller cells with subsequent intracellular fluid accumulation, and dysfunction of the retinal pigment epithelium resulting from the effect of taxanes on microtubule function.[1],[2],[3] In the present case, UWF FA findings added that there was no involvement of peripheral retinal vessel in the development of CME in the patient's eyes. In addition, choroidal hyperpermeability, which is considered a major cause of subretinal or intraretinal fluid in pachychoroid disorders, was not evident on ICGA, and there were no changes in the choroidal large vessels nor vortex ampullae. These results imply that the choroidal vessels are not involved in the development of CME caused by paclitaxel.

Declaration of patient consent

The authors certify that they have obtained all appropriate patient consent forms. In the form the patient(s) has/have given his/her/their consent for his/her/their images and other clinical information to be reported in the journal. The patients understand that their names and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.

  References Top

Joshi MM, Garretson BR. Paclitaxel maculopathy. Arch Ophthalmol 2007;125;709-10. doi: 10.1001/archopht.125.5.709.  Back to cited text no. 1
Smith SV, Benz MS, Brown DM. Cystoid macular edema secondary to albumin-bound paclitaxel therapy. Arch Ophthalmol 2008;126;1605-6. doi: 10.1001/archopht.126.11.1605.  Back to cited text no. 2
Baskin DE, Garg SJ. Abraxane-induced cystoid macular edema refractory to concomitant intravenous bevacizumab. Can J Ophthalmol 2011;46:200-1. doi: 10.3129/i11-001.  Back to cited text no. 3


  [Figure 1], [Figure 2], [Figure 3]


    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

  In this article
Article Figures

 Article Access Statistics
    PDF Downloaded78    
    Comments [Add]    

Recommend this journal